|
Real-time Estimate
Cboe BZX
00:37:17 07/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 175.43 USD | +11.85% |
|
+18.93% | +66.05% |
| 08:24pm | Oppenheimer Adjusts Palvella Therapeutics Price Target to $232 From $210, Maintains Outperform Rating | MT |
| 11-05 | Palvella Therapeutics Shares Drop After Q3 Net Loss Widens | MT |
| Market Cap | 2.26B 2.03B 1.85B 1.69B 3.19B 212B 3.29B 22.33B 8.9B 113B 8.48B 8.3B 358B | P/E 2026 * |
-24x | P/E 2027 * | -17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.07B 1.86B 1.7B 1.55B 2.92B 195B 3.01B 20.45B 8.15B 104B 7.77B 7.6B 328B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 91.8x |
| Free-Float |
88.79% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PVLA | Delayed | |
CBOE
| PVLA | Real-time | |
|
Tradegate
| PI6 | Real-time | |
|
Boerse Muenchen
| PI6 | Real-time | |
|
Deutsche Boerse AG
| PI6 | End-of-day quote |
Last Transcript: Palvella Therapeutics, Inc.
| 1 day | +11.85% | ||
| 1 week | +18.93% | ||
| Current month | +18.93% | ||
| 1 month | +35.79% | ||
| 3 months | +12.19% | ||
| 6 months | +33.53% | ||
| Current year | +66.05% |
| 1 week | 141.98 |  | 176.94 |
| 1 month | 118.22 | | 176.94 |
| Current year | 72.22 | | 176.94 |
| 1 year | 72.22 | | 176.94 |
| 3 years | 11.17 | | 176.94 |
| 5 years | 11.17 | | 176.94 |
| 10 years | 11.17 | | 176.94 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/10/26 | Sell | Chairman | -7,174 | 0.0498% | ||
| 16/09/26 | Exercice | Chief Operating Officer | 12,906 | 0.0896% | ||
| 15/09/26 | Sell | Chairman | -1,777 | 0.0123% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +11.85% | +18.93% | +121.05% | - | 2.26B | |
| -4.83% | +2.88% | +55.87% | +69.12% | 69.4B | |
| +0.02% | +1.07% | +10.63% | +76.66% | 57.24B | |
| -1.34% | +2.98% | +24.79% | +100.18% | 57.62B | |
| +3.17% | +1.69% | +28.92% | +37.02% | 43.65B | |
| +5.62% | +10.56% | +23.19% | +108.75% | 44.03B | |
| +9.34% | +1.07% | +215.02% | +797.68% | 38.08B | |
| -1.86% | +11.46% | +26.67% | +61.40% | 36.31B | |
| -2.97% | -9.84% | +88.86% | +76.17% | 32.61B | |
| -2.18% | +5.68% | +36.21% | -0.69% | 25.47B | |
| Average | +1.69% | +2.36% | +63.12% | +147.37% | 40.67B | |
| Weighted average by Cap. | +0.35% | +2.44% | +52.74% | +139.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 24.63M 22.09M 20.19M 18.43M 34.72M 2.32B 35.82M 243M 97.04M 1.24B 92.45M 90.47M 3.9B |
| Net income | -94.52M -84.78M -77.48M -70.73M -133M -8.89B -137M -934M -372M -4.74B -355M -347M -14.97B | -137M -123M -112M -102M -193M -12.87B -199M -1.35B -540M -6.87B -514M -503M -21.69B |
| Net Debt | -191M -171M -156M -143M -269M -17.92B -277M -1.88B -751M -9.56B -715M -700M -30.18B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/11/26 | $173.81 | +10.81% | 381,157 |
| 05/11/26 | $156.85 | -3.35% | 269,522 |
| 04/11/26 | $162.28 | +6.11% | 407,143 |
| 03/11/26 | $152.93 | +4.51% | 339,565 |
| 02/11/26 | $146.33 | +0.12% | 303,459 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PVLA Stock
Select your edition
All financial news and data tailored to specific country editions
